Acute respiratory viral infection
Not recommended
For URI, Ergoferon is absent from international sources. URI is self-limiting; management is symptomatic. Homeopathic preparations are not mentioned in , , , or CDC URI guidance.
Homeopathic preparation marketed as an immunomodulator (local classification)
ATC code: V03AX-ERGOFERON (Ergoferon (homeopathic antibody dilutions) – local code)
The manufacturer claims «activated-potentiated forms» of antibodies to γ-interferon, the CD4 receptor, and histamine. The preparation is homeopathic: dilutions exceed Avogadro's number, with less than one molecule of active substance per dose. Such dilutions lack biological plausibility under standard pharmacology. Developed and sold by Materia Medica Holding (Russia); chief – O.I. Epshtein.
Not recommended
For URI, Ergoferon is absent from international sources. URI is self-limiting; management is symptomatic. Homeopathic preparations are not mentioned in , , , or CDC URI guidance.
Not recommended
For herpes, Ergoferon is absent from guidelines. Proven antiherpetic agents are nucleoside analogues aciclovir, valacyclovir, and famciclovir.
Not recommended
For influenza, Ergoferon is absent from , 2018, and guidelines. Proven antivirals are neuraminidase inhibitors (oseltamivir, zanamivir) and baloxavir. Homeopathic preparations are absent from influenza recommendation tables as a class.
Not recommended
— Immune system boosting: Ergoferon is marketed as a universal «immunomodulator» for children and adults with recurrent infections. The preparation is homeopathic: dilutions exceed Avogadro's number with no biologically active quantity per dose. , , , and international guidelines do not list the product. Evidence-based measures: influenza and pneumococcal vaccination, hand hygiene, removal of secondhand smoke.
Pregnancy and breastfeeding use is not studied per the label; the manufacturer does not recommend.
The manufacturer does not recommend use during breastfeeding.
Ergoferon (antibodies to γ-interferon, CD4, and histamine in homeopathic dilutions) is evaluated for the following indications with varying evidence strength: Acute respiratory viral infection (evidence tier F), Herpes simplex (evidence tier F), Influenza (evidence tier F). See the full indication matrix with dosing and citations above on this page.
Common side effects of Ergoferon (antibodies to γ-interferon, CD4, and histamine in homeopathic dilutions) (≥ 1 in 100): Allergic reactions (rare per label). See the Safety section for uncommon and serious reactions.
Pregnancy and breastfeeding use is not studied per the label; the manufacturer does not recommend.
The manufacturer does not recommend use during breastfeeding.
Ergoferon (antibodies to γ-interferon, CD4, and histamine in homeopathic dilutions) is contraindicated in: Age under 6 months; Hypersensitivity; Lactose intolerance. Full list in the Safety section.